The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Frantz, Douglas
Funded by
UTSA VPR Office
To develop therapeutic approaches for addressing the COVID-19 pandemic. this project brings together researchers with multidisciplinary and complementary expertise in theoretical and computational biophysics (PI Vashisth. UNH). biophysical chemistry and NMR spectroscopy (co-PI Varga. UNH). and small- molecule drug discovery (co-PI Doug E. Frantz. UTSA). The partnership and collaboration are timely and strategic in that the first experimental structure of the protease enzyme and its potential inhibitors have just been reported. Dr.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
Xenex Disinfection Services LLC
The goal of this project is to evaluate the capacity of Xenex UV Disinfection systems to inactivate live SARS-CoV-2.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
Southwest Research Institute
The primary objective of this project is to identify drug compounds that may inhibit SARS-CoV-2 replication in an in vitro tissue culture assay. Vero E6 cells will be used to evaluate the effectiveness of the test articles to inhibit SARS-CoV-2 replication.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Mohan, Mahesh
The proposed studies is aimed at understanding the molecular mechanisms underlying oral mucosal dysfunction and developing novel immune
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Bach, Stephan
Funded by
US Dept of Agriculture
Complete concentration analysis of eprinomectin in serum obtained from blood samples collected at the USDA, ARS, Cattle Fever Tick Research Laboratory (CFTRL) in collaboration with the ARS scientists in support of the continuation of research studying the interaction between Bm86 vaccine and a long-acting eprinomectin injectable formulation. Blood samples collected during the study will be processed at the USDA, ARS, CFTRL to obtain serum. ARS will provide the serum samples to the University of Texas at San Antonio (UTSA) to conduct the analysis per the one year field study.
